MedTrace Logo

Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous Women

NCT01001897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2012-06-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate if the use of misoprostol can make it easier for a provider, and less painful for a woman, to place an IUD if she has never had a child before.

Conditions

  • Contraception

Interventions

DRUG

Misoprostol

400 micrograms of misoprostol or placebo inserted buccally or vaginally prior to IUD insertion

DRUG

Placebo

400 micrograms of misoprostol or placebo inserted buccally or vaginally prior to IUD insertion

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-01-31
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01001897 on ClinicalTrials.gov